Timed and targeted therapy for acute kidney injury: a glimpse of the future
- 1 June 2010
- journal article
- editorial
- Published by Elsevier in Kidney International
- Vol. 77 (11) , 947-949
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial)Kidney International, 2010
- Preexisting Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2009
- Prerenal failure: from old concepts to new paradigmsCurrent Opinion in Critical Care, 2009
- Evaluation of Trial Outcomes in Acute Kidney Injury by Creatinine ModelingClinical Journal of the American Society of Nephrology, 2009
- ESAs to treat anemia—balancing the risks and benefitsNature Reviews Clinical Oncology, 2009
- A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injuryNephrology Dialysis Transplantation, 2009
- Chapter 4 Urinary Biomarkers for the Detection of Renal Injury2009
- Erythropoietin and renoprotectionCurrent Opinion in Nephrology and Hypertension, 2009
- Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injuryCritical Care, 2007
- Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) GroupCritical Care, 2004